Therapy News and Research

RSS

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies.

20 Apr 2009

Effect of 18F-FDG PET/CT in esophageal cancer patients with early recurrence lesions

In the initial staging of esophageal cancer, preoperative PET scan may be useful in detecting additional cases of metastatic disease before costly and toxic definitive therapy.

20 Apr 2009

Statins may be useful in patients with tamoxifen-resistant breast cancer

Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).

20 Apr 2009

Exposure to Agent Orange increases risk of aggressive recurrence of prostate cancer

Veterans exposed to Agent Orange are at increased risk of aggressive recurrence of prostate cancer, researchers report.

20 Apr 2009

Acupuncture relieves symptoms of xerostomia

Twice weekly acupuncture treatments relieve debilitating symptoms of xerostomia - severe dry mouth - among patients treated with radiation for head and neck cancer, researchers from The University of Texas M. D. Anderson Cancer Center report in the current online issue of Head & Neck.

20 Apr 2009

Molecular profiling helps cancer patients survive

Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations.

20 Apr 2009

New imaging analysis method predicts brain tumor survival

As early as one week after beginning treatment for brain tumors, a new imaging analysis method was able to predict which patients would live longer, researchers from the University of Michigan Comprehensive Cancer Center have found.

20 Apr 2009

OptiNose releases novel nasal drug delivery device trial data

OptiNose has announced important new results from a Phase II trial of its novel nasal drug delivery device with fluticasone for the treatment of chronic rhinosinusitis.

20 Apr 2009

New therapy for pancreatic cancer achieves tumor remission and prevents recurrence

Pancreatic cancer remains one of the deadliest cancers, but researchers may have found a combination therapy to reduce cancer stem cells and stop pancreatic cancer growth. Results will be presented at the American Association for Cancer Research 100th Annual Meeting 2009.

20 Apr 2009

New biomarker may predict aggressiveness of chronic lymphocytic leukemia

Scientists at the University of California, San Diego and the Moores UCSD Cancer Center have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia.

20 Apr 2009

Laughter improves health

The connection between the body, mind and spirit has been the subject of conventional scientific inquiry for some 20 years.

20 Apr 2009

Brain metastases hijack neuron-supporting cells to resist chemotherapy

Cancer that spreads to other organs finds a particularly inviting hideout in the brain, where these metastases are usually far harder to treat than they are in other locations.

20 Apr 2009

Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers

The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.

20 Apr 2009

Women who wear veils risk vitamin D deficiency

A study by Australian scientists has found that women who wear veils for religious or cultural reasons may not be getting enough vitamin D.

20 Apr 2009

Star Scientific reports on patent application for Zero-Nitrosamine tobacco curing process

Star Scientific and its wholly-owned subsidiary, Rock Creek Pharmaceuticals ("Rock Creek"), have reported on their continuing efforts to lessen the harm linked with tobacco use.

16 Apr 2009

Nanoparticles combined with scorpion venom slow spread of brain cancer

By combining nanoparticles with a scorpion venom compound already being investigated for treating brain cancer, University of Washington researchers found they could cut the spread of cancerous cells by 98 percent, compared to 45 percent for the scorpion venom alone.

16 Apr 2009